Little light reading about the other

New Post Public Reply Private Reply Replies (0) Message Board
avboy






Little light reading about the other companies.





Dividend Kings



Profile| Send Message| Follow (840 followers)





Which 5 Energy Drink Stocks Can Boost Your Portfolio?

Nov. 28, 2012 10:40 AM ET | 3 comments | Includes: DPS, KO, KOF, MNST, PEP









Energy drinks may seem like a great growth market for non-alcoholic beverage firms. But investors should exercise caution before buying in. Whether true or false, there are many suspicions and allegations about health problems associated with energy drinks. Investors should require low valuations to compensate for this bad publicity and any legal risks that may come from these tragic events.



This article was sent to 1,894 people who get email alerts on DPS.

Get email alerts on DPS »


Health Issues for Red Bull

The U.S. Food and Drug Administration released a list of reported health problems which were somehow associated or connected to energy drinks. Problems that coincided with consuming energy drinks included increased heart rate and abdominal pains. With incidents dating back to 2004, the report included incidents associated with drinks like 5-Hour Energy, Monster Beverage (NASDAQ:MNST) and Rockstar.

In summary, 5-Hour Energy drink was linked to 92 incidents that included 33 hospitalizations and 13 deaths. Red Bull was mentioned in 21 event reports, including four incidents of hospitalizations. Monster drink had 40 reports, including five fatalities and 20 hospital check-ins. Rockstar recorded no fatalities, but was identified in 13 incidents. Though it could be found that there is no meaningful connection between these medical issues and the consumption of energy drinks, there is a risk that some connection could be established.

The U.S. Food and Drug Administration requires U.S. beverage companies to indicate caffeine levels are safe if they exceed a certain concentration. The FDA said that the common soft drink should contain no more than 71 milligrams of caffeine in every 12 ounces to ensure safe caffeine levels. If caffeine is more concentrated, it is required to be reported. A Red Bull energy drink has 80 mg of caffeine.

Nothing has been proven so far, and any connections are no more than allegations or speculation at this point. Regardless, this bad press does not make you want to gulp down a Monster energy drink.

Bad PR Under Monster's Bed

Monster Beverage stock plunged by 11% upon the announcement of disappointing third-quarter sales. The news was good, but worse than expected. Third-quarter income increased to $86.1 million by 4.6% year-over-year, up from $82.6 million. Sales missed the analysts' average estimate by 14% at $578.4 million. This was Monster's slowest period for revenue growth since 2010.

Why did sales growth slow down? The fall in revenue is blamed on bad press that has come from five people dying after drinking Monster energy drinks over the past year.

The investigations conducted by the U.S. Food and Drug Administration have exonerated the company. No link was found between the deaths and the beverage consumption. Monster Beverage CEO Rodney Sacks stated that there is no evidence connecting the beverages to these tragic events. He said, "There is not a shred of information which causally links Monster to these adverse events."

New regulations may be spawned from these tragic events. Senators Richard Blumenthal of Connecticut, and Richard Durbin of Illinois, demanded that the FDA clarify whether energy drinks qualify as dietary supplements.

Pepsi Going Flat

The question of health issues surrounding energy drinks is not the only challenge facing non-alcoholic beverage stocks. Some beverage companies are having a hard time growing. PepsiCo (NYSEEP) experienced a 5 percent drop in net income versus the third quarter of 2011. Sales also dropped 5.3 percent between the period.

But these results were widely regarded as good news as they beat analyst expectations. PepsiCo CFO Hugh Johnston stated, "I expect to see, with our balanced portfolio, continued growth in our core beverage business."

Regardless of how these results were presented, they were not growth. Investors should not pay above-market price multiples for declining earnings and sales.

A Bumpy Ride for Coca-Cola Femsa (NYSE:KOF)

Is there revenue growth and earnings growth made possible by overseas expansion? Yes. However, investors should be warned that this growth is found in volatile markets.

Mexican bottler Coca-Cola Femsa reported strong numbers for its third quarter. Revenue grew 20.3% year-over-year. Sales from existing territories increased 9.6%. Increases in operating margins made combined operating income grow even faster at a rate of 26.6%. Better margins widened operating income from existing territories, which increased 18%. There was growth in the bottom line as well, with controlling interest income growing 53.5% for the third quarter. CEO Carlos Salazar Lomelin said, "After facing a very tough commodity and volatile currency environment over the past several quarters, we look forward to a strong close of the year."

The third quarter was a dream compared with the nightmare seen in the second quarter of 2012. Coca-Cola Femsa's second-quarter profits came in 8.4% below analyst estimates. American investors were disappointed in their Coca-Cola Femsa positions based on a weakening peso, which slid by 12% against the dollar. Net income fell 9 percent with the cost of labor and freight increasing in Argentina and Venezuela, which pushed theses expenses up by about 38%. Chief Financial Officer Hector Trevinor said, "Should currency volatility recede, we look forward to a more stable cost environment for the second half of 2012."

The company is also moving into Asia. Coca-Cola Femsa is expanding beyond Latin America with a Coca-Cola unit in the Philippines.

Valuation

Monster is not trading at a discount:








Ticker

Company

P/E

P/S

P/B


DPS

Dr Pepper Snapple

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JIMMY's Nespure N9: Innovating Coffee and Clean Water

Updated Category News Views 2

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...

Continue Reading
CRESYN Opens Model Residence: A Peek at City Living

Updated Category News Views 0

CRESYN: Urban Elegance Hits Long Island City Who doesn't want to peek under the hood when a flashy new ride rolls into town? CRESYN's newly unveiled model residence in Long Island City is just that—an invitation to get up close and personal with what modern urban living can be. Forget the blueprints and glossy renderings. This place is the real deal, giving you that...

Continue Reading
Yardi Virtuoso AI to Shine at CAIC 2026 Toronto

Updated Category News Views 3

The Scene in Toronto: Yardi's Big AI Showcase There's no denying it—Artificial Intelligence has muscled its way into practically every corner of the business world, and now it's making waves in real estate. Yardi, a familiar name in real estate tech circles, is gearing up to flaunt its Yardi Virtuoso Enterprise at the Canadian Apartment Investment Conference (CAIC) in...

Continue Reading
Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 3

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
Haier and UEFA's Deal: A Game-Changer for Fans?

Updated Category News Views 1

A Bold Play in the Global Arena There's something big brewing on the horizon, as Haier aligns with the UEFA Champions League. From 2027 to 2031, this move isn't just about slapping a logo on a jersey. Nah, it's more than that. Haier's stepping up its game, aiming to become a real player in weaving technology and sports into the daily lives of millions. "We aim to bring...

Continue Reading
What to Expect from KeyCorp at Barclays Event

Updated Category News Views 1

KeyCorp's Next Move: An Insider's View Yep, circle that calendar, folks. Looks like KeyCorp's gonna be laying it all out there for the financial world to see. Clark Khayat, their numero uno money guy, is hitting the stage at the Barclays Global Financial Services Conference on Sept. 14. So grab the popcorn—or, more like, your portfolio tracker—because this could get...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 0

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading
Innovation Drives New Asia-Pacific Opportunities

Updated Category News Views 1

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

Continue Reading
Better's 90-Day Plan: Growth Amidst Governance Gamble

Updated Category News Views 3

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Continue Reading

Top 5 Most Recently Viewed Articles

Automotive Bushing Market Expected to Exceed $264 Billion

Updated Category News Views 140

Automotive Bushing Market Overview The Automotive Bushing Market is anticipated to reach USD 264.30 billion by 2032, experiencing a compound annual growth rate (CAGR) of 5.14% from 2024 to 2032. This growth is largely attributed to the rising demand for higher-end vehicles in emerging markets. As consumers increasingly seek comfort and performance, there is a noticeable...

Continue Reading
Select Water Solutions Engages in Fireside Chat Series

Updated Category News Views 100

Select Water Solutions to Join Fireside Chat Series Select Water Solutions, Inc. (NYSE: WTTR) is a key player in offering sustainable water and chemical solutions tailored for the energy sector. Recently, the company announced their participation in the Water Tower Research Fireside Chat Series, featuring two of their top executives, Chris George, who serves as the...

Continue Reading
Innovative Partnership Unveils New Potential in CNS Treatments

Updated Category News Views 194

Lynk Pharmaceuticals and Formation Bio Partnership Lynk Pharmaceuticals Co., Ltd. and Formation Bio have recently entered into an exclusive development and licensing agreement regarding LNK01006. This exciting collaboration opens up new avenues for treatment focused on enhancing central nervous system health. Understanding LNK01006 LNK01006 is a notable innovation,...

Continue Reading
Cloud Capital Announces Successful Close of Fund II Investment

Updated Category News Views 170

Cloud Capital Fund II Achieves Final Close, Attracting Investors Cloud Capital, a prominent name in global data center investment management, has announced a significant milestone with the completion of the final close for Cloud Capital Fund II. This closed-end investment vehicle is focused on strategizing and acquiring high-quality data centers, highlighting its...

Continue Reading
Analyzing Investor Sentiments Toward Paycom Software

Updated Category News Views 169

Understanding Short Interest in Paycom Software Paycom Software's short percent of float has increased to 4.63% as indicated in its latest report, reflecting a total of 2.22 million shares sold short. This equates to approximately 4.75% of the company's available shares for trading. On average, it currently takes traders about 4.75 days to cover their short positions...

Continue Reading